HUGEL, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 201,000 KRW | -2.19% |
|
-3.37% | +34.54% |
| Mar. 27 | Hugel, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares. | CI |
| Mar. 27 | Hugel, Inc. authorizes a Buyback Plan. | CI |
Chart calendar Hugel, Inc.
5dc89b.RU_wR3RPU_l_JixBqZrwWNFjK5gjFz-vK6KQs5jNMyY.CRDAHkIXC70nfn8vy_KBbeEabdZlc3uZQe3fw-v6YWAGCoByWQMBsTVqXw~a69db2a2ca59585d9e8082dcab2c9361
Upcoming events on Hugel, Inc.
Past events on Hugel, Inc.
| 2024-02-14 02:19 am | Q4 2023 Sales and Revenue Release |
| 2024-02-13 | Q4 2023 Earnings Release |
| 2023-11-15 | Non Deal Roadshow - Day 2 |
| 2023-11-14 | Non Deal Roadshow - Day 1 |
| 2023-11-13 08:00 am | Q3 2023 Earnings Release |
| 2023-11-12 | Q3 2023 Earnings Call |
| 2023-10-30 | KOSDAQ Global IR Conference |
| 2023-08-16 | Investor Meeting - Day 2 |
| 2023-08-15 | Investor Meeting - Day 1 |
| 2023-08-09 02:30 am | Q2 2023 Earnings Call |
| 2023-08-08 | Q2 2023 Earnings Release |
| 2023-05-24 | Samsung Securities Global Conference |
| 2023-05-15 | Roadshow |
| 2023-05-14 | Roadshow - Day 1 |
| 2023-05-10 02:30 am | Q1 2023 Earnings Call |
| 2023-05-09 | Q1 2023 Earnings Release |
| 2023-03-29 | Shareholders Meeting |
| 2023-02-09 09:00 am | Q4 2022 Earnings Release |
| 2022-11-13 | Q3 2022 Earnings Release |
| 2022-08-15 | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 205 206 -0.82% | 211 208 1.22% | 245 242 1.45% | 282 278 1.2% | 320 322 -0.79% | 383 |
|
EBITDA Billions KRW | Released Forecast Spread | 77,6 78,4 -1.03% | 88,8 86,1 3.06% | 111 109 1.83% | 115 109 6.1% | 132 127 3.72% | 161 |
|
EBIT Billions KRW | Released Forecast Spread | 68,1 69,8 -2.51% | 78,2 76,1 2.76% | 97,1 97,1 0% | 102 96,7 5.99% | 118 115 2.31% | 149 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 69,7 74,4 -6.29% | 81,7 74,6 9.58% | 89,0 93,9 -5.21% | 66,5 104 -35.88% | 133 132 0.59% | 148 |
|
Net income Billions KRW | Released Forecast Spread | 44,6 51,9 -14.05% | 51,9 47,3 9.61% | 57,5 65,2 -11.72% | 57,7 71,5 -19.39% | 92,3 96,4 -4.23% | 106 |
|
EPS KRW | Released Forecast Spread | 3 532 3 823 -7.62% | 3 344 4 122 -18.87% | 4 658 5 229 -10.92% | 4 545 5 843 -22.21% | 7 934 7 915 0.24% | 9 068 |
| Announcement Date | 12/03/20 | 09/02/21 | 10/02/22 | 09/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 61,0 57,4 6.33% | 64,9 63,5 2.12% | 67,4 69,0 -2.29% | 70,7 70,5 0.29% | 85,5 75,2 13.67% | 64,4 76,7 -16.01% | 81,6 77,5 5.23% | 84,8 81,0 4.78% | 88,9 91,7 -2.97% | 79,0 | 91,3 | 110 | 107 |
|
EBITDA Billions KRW | Released Forecast Spread | 32,8 28,4 15.57% | 21,9 30,3 -27.8% | 31,4 30,5 2.89% | 37,7 27,8 35.56% | 40,3 38,5 4.78% | 28,5 | 41,0 | 45,5 | 46,5 | ||||
|
EBIT Billions KRW | Released Forecast Spread | 19,7 20,3 -2.61% | 25,0 24,0 4.32% | 22,3 24,3 -8.21% | 24,8 23,5 5.28% | 31,2 25,4 22.78% | 18,5 25,9 -28.57% | 28,0 23,4 19.42% | 34,6 26,3 31.63% | 36,8 33,3 10.54% | 26,8 | 34,0 | 45,9 | 43,2 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 11,4 21,2 -46.15% | 22,1 24,0 -7.77% | 23,2 26,2 -11.6% | 31,9 26,8 19.19% | -12,6 28,2 -144.61% | 24,3 28,3 -14.21% | 30,9 25,3 22% | 53,7 28,9 85.64% | 24,0 32,6 -26.35% | 29,3 | 30,2 | 38,2 | 46,1 |
|
Net income Billions KRW | Released Forecast Spread | 3,72 16,8 -77.88% | 15,0 14,1 6.11% | 14,8 18,3 -19.23% | 25,8 17,3 48.62% | 2,14 18,3 -88.26% | 16,4 19,2 -14.49% | 21,1 17,6 20.28% | 39,4 19,9 98.45% | 15,4 18,9 -18.19% | 22,3 | 23,0 | 29,2 | 35,2 |
| Announcement Date | 10/02/22 | 11/05/22 | 10/08/22 | 10/11/22 | 09/02/23 | 10/05/23 | 09/08/23 | 13/11/23 | 14/02/24 | - | - | - | - |
| 2024-05-06 07:00 am | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 | BIOTEST AG: Q1 2024 Earnings Release |
| 2024-05-06 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 02:00 am | BIOGAIA AB: Q1 2024 Earnings Release |
| 2024-05-07 07:30 am | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
| 2024-05-08 07:55 am | VERICEL CORPORATION: Q1 2024 Earnings Release |
| 2024-05-08 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
Past sector events for Hugel, Inc.
| 2024-05-02 04:05 pm | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 2024-05-02 07:50 am | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:30 am | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-30 07:00 am | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 2024-04-29 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-29 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-29 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release |
| 2024-04-29 05:53 pm | SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release |
| 2024-04-28 | SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A145020 Stock
- Calendar Hugel, Inc.
